Sage Therapeutics Inc (SAGE)
8.68
0.00 (0.00%)
USD |
NASDAQ |
Aug 11, 16:00
Sage Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2025 | 0.031 |
| March 31, 2025 | 0.0289 |
| December 31, 2024 | 0.0254 |
| September 30, 2024 | 0.0186 |
| June 30, 2024 | 0.0022 |
| March 31, 2024 | 0.0047 |
| December 31, 2023 | 0.0065 |
| September 30, 2023 | 0.0085 |
| June 30, 2023 | 0.0089 |
| March 31, 2023 | 0.0092 |
| December 31, 2022 | 0.0097 |
| September 30, 2022 | 0.01 |
| June 30, 2022 | 0.0102 |
| March 31, 2022 | 0.0105 |
| December 31, 2021 | 0.0107 |
| September 30, 2021 | 0.0108 |
| June 30, 2021 | 0.0111 |
| March 31, 2021 | 0.0113 |
| December 31, 2020 | 0.0136 |
| September 30, 2020 | 0.0451 |
| June 30, 2020 | 0.0422 |
| March 31, 2020 | 0.0415 |
| December 31, 2019 | 0.0393 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.036 |
| June 30, 2019 | 0.0338 |
| March 31, 2019 | 0.0316 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Abeona Therapeutics, Inc. | 0.1552 |
| America Great Health | -0.6512 |
| Acumen Pharmaceuticals, Inc. | 0.5526 |
| Aardvark Therapeutics, Inc. | 0.0091 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 422.92M |
| Total Liabilities (Quarterly) | 54.18M |
| Shareholders Equity (Quarterly) | 368.74M |